Adage Capital Partners’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-350,000
| Closed | -$43.9M | – | 1118 |
|
|
2021
Q2 | $43.9M | Buy |
+350,000
| New | +$43.9M | 0.09% | 242 |
|
|
2018
Q3 | – | Sell |
-108,500
| Closed | -$5.26M | – | 780 |
|
|
2018
Q2 | $5.26M | Buy |
+108,500
| New | +$5.26M | 0.01% | 644 |
|
|
2016
Q4 | – | Sell |
-169,500
| Closed | -$6.13M | – | 744 |
|
|
2016
Q3 | $6.13M | Sell |
169,500
-118,000
| -41% | -$4.27M | 0.02% | 591 |
|
|
2016
Q2 | $9.77M | Sell |
287,500
-100,000
| -26% | -$3.4M | 0.03% | 518 |
|
|
2016
Q1 | $10.2M | Hold |
387,500
| – | – | 0.03% | 509 |
|
|
2015
Q4 | $18.9M | Sell |
387,500
-531,555
| -58% | -$25.9M | 0.05% | 383 |
|
|
2015
Q3 | $22.9M | Sell |
919,055
-255,945
| -22% | -$6.37M | 0.06% | 354 |
|
|
2015
Q2 | $37.2M | Sell |
1,175,000
-25,000
| -2% | -$791K | 0.09% | 278 |
|
|
2015
Q1 | $45.7M | Sell |
1,200,000
-572,406
| -32% | -$21.8M | 0.11% | 243 |
|
|
2014
Q4 | $69.1M | Buy |
1,772,406
+25,000
| +1% | +$974K | 0.17% | 160 |
|
|
2014
Q3 | $52.8M | Buy |
1,747,406
+226,740
| +15% | +$6.86M | 0.13% | 204 |
|
|
2014
Q2 | $51.7M | Buy |
1,520,666
+178,469
| +13% | +$6.06M | 0.13% | 203 |
|
|
2014
Q1 | $46.3M | Buy |
1,342,197
+817,197
| +156% | +$28.2M | 0.13% | 215 |
|
|
2013
Q4 | $20.8M | Buy |
+525,000
| New | +$20.8M | 0.06% | 392 |
|